| 
Citations
 | 
   web
Azar, M., Carrasco, R. A., & Mondschein, S. (2022). Dealing with Uncertain Surgery Times in Operating Room Scheduling. Eur. J. Oper. Res., 299(1), 377–394.
toggle visibility
Barrera, J., Carrasco, R. A., Mondschein, S., Canessa, G., & Rojas-Zalazar, D. (2020). Operating room scheduling under waiting time constraints: the Chilean GES plan. Ann. Oper. Res., 286(1-2), 501–527.
toggle visibility
Bitran, G., & Mondschein, S. (2015). Why individualized contact policies are critical in the mass affluent market. Acad.-Rev. Latinoam. Adm., 28(2), 251–272.
toggle visibility
Garmendia, M. L., Matus, O., Mondschein, S., & Kusanovic, J. P. (2018). Gestational weight gain recommendations for Chilean women: a mathematical optimization approach. Public Health, 163, 80–86.
toggle visibility
Garmendia, M. L., Mondschein, S., Matus, O., Murrugarra, R., & Uauy, R. (2017). Predictors of gestational weight gain among Chilean pregnant women: The Chilean Maternal and Infant Nutrition Cohort study. Health Care Women Int., 38(8), 892–904.
toggle visibility
Garmendia, M. L., Mondschein, S., Montiel, B., & Kusanovic, J. P. (2020). Trend and predictors of gestational diabetes mellitus in Chile. Int. J. Gynecol. Obstet., 148(2), 210–218.
toggle visibility
Garmendia, M. L., Mondschein, S., Montiel, B., & Kusanovic, J. P. (2021). Trends and predictors of birth weight in Chilean children. Public Health, 193, 61–68.
toggle visibility
Kong, Q. X., Mondschein, S., & Pereira, A. (2018). Effectiveness of breast cancer screening policies in countries with medium-low incidence rates. Rev. Saude Publica, 52, 9 pp.
toggle visibility
Mondschein, S., Quinteros, M., & Yankovic, N. (2020). Gender bias in the Chilean public health system: Do we all wait the same? Plos One, 15(9), e0239445.
toggle visibility
Mondschein, S., Yankovic, N., & Matus, O. (2021). Age-dependent optimal policies for hepatitis C virus treatment. Int. Trans. Oper. Res., 28(6), 3303–3329.
toggle visibility
Mondschein, S., Yankovic, N., & Matus, O. (2021). The Challenges of Administering a New Treatment: The Case of Direct -Acting Antivirals for Hepatitis C Virus. Public Health, 190, 116–122.
toggle visibility